For example, while OPN promotes inflammatory responses in autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), its absence may lead to the inadequate resolution of inflammation, persistent tissue damage, and low-grade chronic inflammation. This evidence concerns the gene SPP1 and autoimmune disease.